Induction therapy with BRAF/MEK inhibitors versus upfront ipilimumab/nivolumab in poor prognostic advanced melanoma

BRAF/MEK-i showed no significant benefit over upfront IPI/NIVO in matched and stratified analyses according to prognostic characteristics.

Authors

Institutions

Publication Details

Journal
European Journal of Cancer
Published
2025-10-20
DOI
https://doi.org/10.1016/j.ejca.2025.116062
Primary Topic
Melanoma and MAPK Pathways
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Induction therapy with BRAF/MEK inhibitors versus upfront ipilimumab/nivolumab in poor prognostic advanced melanoma

Bart Rikhof, Martin W. Bloem, Astrid A.M. van der Veldt, Geke A.P. Hospers et al.
European Journal of Cancer
Melanoma and MAPK Pathways
article

Induction therapy with BRAF/MEK inhibitors versus upfront ipilimumab/nivolumab in poor prognostic advanced melanoma

Bart Rikhof, Martin W. Bloem, Astrid A.M. van der Veldt, Geke A.P. Hospers, Willeke A.M. Blokx, Jan Willem B. de Groot, C U Blank, Djura Piersma, Ellen Kapiteijn, M J Boers-Sonderen, A M Stevense-den Boer, J.B.A.G. Haanen, Michel W.J.M. Wouters, Lieke H. J. Simkens, Maureen J.B. Aarts, Karijn P.M. Suijkerbuijk, Franchette W.P.J. van den Berkmortel, A.J.M. van den Eertwegh, C D M Boreel
article en

Abstract

BRAF/MEK-i showed no significant benefit over upfront IPI/NIVO in matched and stratified analyses according to prognostic characteristics.

European Journal of CancerVol. 230
Leiden University (NL), University Medical Center Groningen (NL), Radboud University Nijmegen (NL), University of Groningen (NL), Utrecht University (NL), Heidelberg University (DE), Leiden University Medical Center (NL), Maastricht University Medical Centre (NL), Medisch Spectrum Twente (NL), University Hospital Heidelberg (DE), Medisch Centrum Leeuwarden (NL), Radboud University Medical Center (NL), The Netherlands Cancer Institute (NL), University Medical Center Utrecht (NL), Dutch Institute for Clinical Auditing (NL), Amphia Ziekenhuis (NL), Oncode Institute (NL), Máxima Medisch Centrum (NL), Zuyderland Medisch Centrum (NL), Isala (NL), Cancer Center Amsterdam (NL), Amsterdam UMC Location Vrije Universiteit Amsterdam (NL), Erasmus University Rotterdam (NL)
Bristol-Myers Squibb, Les Laboratories Pierre Fabre, ZonMw
Openalex Percentile: Top 74%
Melanoma and MAPK Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.